Rani Therapeutics Holdings (RANI) Minority Interest (2021 - 2026)
Rani Therapeutics Holdings (RANI) posted quarterly Minority Interest of $7.1 million for Q1 2026, up 411.3% year-over-year from $1.4 million in Q1 2025, and down 16.04% quarter-over-quarter from $8.5 million in Q4 2025.
Rani Therapeutics Holdings (RANI) Minority Interest (2021 - 2026) Analysis & Trends
Rani Therapeutics Holdings' Minority Interest history runs 6 years deep, the most recent figure standing at $7.1 million for Q1 2026.
- In Q1 2026, Minority Interest rose 411.3% year-over-year to $7.1 million; the TTM figure through Mar 2026 stood at $7.1 million (up 411.3% YoY), while the FY2025 annual figure was $8.5 million, up 466.42% from the prior year.
- Minority Interest for Q1 2026 stood at $7.1 million, down from $8.5 million in the prior quarter.
- The five-year high for Minority Interest was $57.3 million in Q1 2022, with the low at -$4.1 million in Q3 2025.
- The 5-year median for Minority Interest is $8.5 million (2025), against an average of $17.3 million.
- Peak annual rise in Minority Interest reached 466.42% in 2025, while the deepest fall reached 254.92% in 2025.
- Rani Therapeutics Holdings' Minority Interest stood at $37.1 million in 2022, then sank by 66.14% to $12.6 million in 2023, then slumped by 88.07% to $1.5 million in 2024, then surged by 466.42% to $8.5 million in 2025, then dropped by 16.04% to $7.1 million in 2026.
- Business Quant data shows RANI's Minority Interest at $7.1 million in Q1 2026, $8.5 million in Q4 2025, and -$4.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Rani Therapeutics Holdings | 160.33 Mn | 160.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.75 Mn |
| Mar 31, 2026 | 7.14 Mn |
| Dec 31, 2025 | 8.50 Mn |
| Sep 30, 2025 | -4.11 Mn |
| Jun 30, 2025 | -3.58 Mn |
| Mar 31, 2025 | -2.29 Mn |
| Dec 31, 2024 | 1.50 Mn |
| Sep 30, 2024 | 2.66 Mn |
| Jun 30, 2024 | 2.72 Mn |
| Mar 31, 2024 | 7.14 Mn |
| Dec 31, 2023 | 12.58 Mn |
| Sep 30, 2023 | 17.27 Mn |
| Jun 30, 2023 | 24.08 Mn |
| Mar 31, 2023 | 30.87 Mn |
| Dec 31, 2022 | 37.15 Mn |
| Sep 30, 2022 | 44.41 Mn |
| Jun 30, 2022 | 50.84 Mn |
| Mar 31, 2022 | 57.26 Mn |
| Dec 31, 2021 | 74.16 Mn |
| Sep 30, 2021 | 80.34 Mn |